| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $464.9M | -2.2% | +7.7% |
| Cost of Revenue | $418.3M | -7.5% | +7.5% |
| Gross Profit | $46.6M | +102.3% | +9.5% |
| R&D Expense | $21.1M | +13.6% | -4.7% |
| SG&A Expense | $37.2M | -11.0% | -10.1% |
| Pre-tax Income | -$27.7M | +60.7% | +36.9% |
| Income Tax | $1.5M | +119.6% | +177.4% |
| Net Income | -$20.9M | +53.6% | +32.6% |
| EPS (Basic) | -$0.16 | +52.9% | +33.3% |
| EPS (Diluted) | -$0.16 | +52.9% | +33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $387.3M | -14.4% | -31.9% |
| Accounts Receivable | $180.1M | -37.6% | +20.9% |
| Inventory | $764.2M | +41.3% | +9.4% |
| Current Assets | $2.08B | +4.8% | +2.5% |
| Total Assets | $2.35B | +3.4% | +3.3% |
| Current Liabilities | $1.45B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$347.9M | -53.4% | — |
| Capital Expenditures | $8.3M | +42.6% | — |
| Investing Cash Flow | -$16.1M | -72.3% | — |
| Financing Cash Flow | $66.6M | +3827.6% | — |
| Free Cash Flow | -$356.2M | -53.1% | — |
| +7.9% |
| Total Liabilities | $1.89B | +6.1% | +6.5% |
| Stockholders' Equity | $368.1M | -5.1% | -5.2% |